Today in Oncology

Novel Cell Profiling Technique May Help Personalize Cancer Treatments2/27/2015 10:46:04 AM - Jo Cavallo

Study Shows Lack of RNA Editing Leads to Melanoma Growth and Metastasis2/26/2015 4:50:42 PM - The ASCO Post

Patient-Reported Outcomes in Hematology and Oncology Product DevelopmentSeptember 15, 2014, Volume 5, Issue 15 - The ASCO Post

Sipuleucel-T Demonstrates Sustained Immune Response 2 Years After Treatmen...2/26/2015 3:44:56 PM - The ASCO Post

Emergency Room Visits and Hospitalizations Are Common Among Women With Ear...2/26/2015 3:11:42 PM - Charlotte Bath

How Accurate Is the Pathologic Assessment of the Partial Mastectomy Specim...October 15, 2014, Volume 5, Issue 16 - Caroline Helwick

Prior Cancer Does Not Affect Outcomes Among Patients With Advanced Lung Ca...2/26/2015 2:28:26 PM - Charlotte Bath

Cost-Effectiveness Analysis of First- and Second-Line Bevacizumab Plus Che...2/24/2015 4:20:58 PM - Matthew Stenger

Smarter Trial Design Saves Money and Produces Better DrugsJanuary 25, 2015, Volume 6, Issue 1 - Ronald Piana

Improved Prognosis for Patients With Estrogen Receptor–Positive Breast Can...2/24/2015 4:04:10 PM - Charlotte Bath

Active Surveillance of Intermediate-Risk Prostate Cancer Associated With D...2/24/2015 4:00:47 PM - The ASCO Post

Adjuvant Sorafenib and Sunitinib Do Not Improve Outcomes in Locally Advanc...2/24/2015 3:55:39 PM - The ASCO Post

Androgen, Estrogen, and Stem Cell Markers Help Predict Recurrence and Surv...November 1, 2014, Volume 5, Issue 17 - Matthew Stenger

Men Who Have Had Testicular Cancer May Be More Likely to Develop Prostate ...2/24/2015 2:29:02 PM - The ASCO Post

Inconclusive Outcome for Lapatinib vs Trastuzumab Plus Capecitabine in Pre...2/24/2015 2:09:11 PM - Matthew Stenger

ASCO Calls for Major Medicaid Reform to Improve Quality Cancer Care for Lo...December 1, 2014, Volume 5, Issue 19 - Jo Cavallo

Early Evidence of Increase in Higher-Risk Prostate Cancers From 2011 to 20...2/24/2015 12:33:00 PM - The ASCO Post

Androgen Receptor Abnormality May Not Be Associated With Primary Resistanc...2/24/2015 11:00:53 AM - The ASCO Post

Power Behind ‘Master’ Gene for Cancer DiscoveredDecember 1, 2014, Volume 5, Issue 19 - The ASCO Post

FDA Approves Panobinostat Combination for the Treatment of Multiple Myelom...2/23/2015 3:59:00 PM - The ASCO Post

Lower 30-Day Mortality, Increased Likelihood of Chemotherapy With Laparosc...2/23/2015 3:07:31 PM - Charlotte Bath

Classic vs Rare EGFR Mutations in Non–Small Cell Lung Cancer Have Distinct...2/23/2015 2:50:38 PM - The ASCO Post

Policy Issues in Molecularly Targeted Therapy: The Science, the Money, the...December 15, 2014, Volume 5, Issue 20 - Margot J. Fromer

New Model Provides Improved Prediction of Breast Cancer Risk in African Am...2/23/2015 1:39:44 PM - Matthew Stenger

Final 8-Year Analysis of Intergroup Trial Shows Survival Benefit With Addi...2/23/2015 12:06:02 PM - Matthew Stenger

Adding Sargramostim to Ipilimumab Improved Overall Survival Among Patients...February 10, 2015, Volume 6, Issue 2 - Charlotte Bath

Japanese Study Indicates Death at Home Is Better for Terminally Ill Cancer...2/23/2015 11:23:14 AM - Matthew Stenger

No Progression-Free Survival Benefit of Adding Bevacizumab to Endocrine Th...2/20/2015 4:19:42 PM - Matthew Stenger

The Role of Integrated Palliative Care in Radiation OncologySeptember 1, 2014, Volume 5, Issue 14 - Jo Cavallo

Sensor Technology May Help Improve the Accuracy of Clinical Breast Exams2/20/2015 3:11:31 PM - The ASCO Post

Axillary Ultrasound After Neoadjuvant Chemotherapy for Node-Positive Breas...2/20/2015 2:03:17 PM - Matthew Stenger

Patient Request/Demand for Clinically Inappropriate Intervention Uncommon ...2/20/2015 1:43:06 PM - Matthew Stenger

Ipilimumab/Sargramostim Improves Overall Survival vs Ipilimumab Alone in P...November 15, 2014, Volume 5, Issue 18 - Jo Cavallo

Risk Assessment for Hodgkin Lymphoma Evolving, Promises Greater Precision ...2/20/2015 2:26:15 PM - Charlotte Bath

Improved TNM Prediction of Survival in HPV‑Related Oropharyngeal Car...2/20/2015 9:21:10 AM - Matthew Stenger

For Triple-Negative Breast Cancer, Adding Carboplatin to Anthracycline/Tax...November 1, 2014, Volume 5, Issue 17 - Charlotte Bath

Study Shows That Previous Cancer ‘False Alarms’ May Discourage Patients Fr...2/19/2015 3:00:47 PM - The ASCO Post

FDA Analysis Explores Relationship Between Response Rate and Survival at T...2/19/2015 2:19:37 PM - Matthew Stenger

Molecular Pathologists vs the FDA: Proposed Regulation of Laboratory-Devel...January 25, 2015, Volume 6, Issue 1 - Caroline McNeil

FDA Grants Cobimetinib Priority Review for Use in Combination With Vemuraf...2/25/2015 10:43:21 AM - The ASCO Post